Business
Cannara Completes Acquisition of Medican Organic Inc.
MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices, with two mega facilities based in Québec spanning over 1,600,000 sq. ft., today announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. (“Medican”), a wholly owned subsidiary of BZAM Ltd., for an aggregate purchase price of $2.8
About this update from Cannara Biotech, Inc.
[{"type":"image","alt":"Cannara Biotech (Québec) Inc.","displaySize":"","headline":null,"caption":"Cannara Biotech (Québec) Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":110,"url":"https://media.zenfs.com/en/globenewswire.com/8d20ac8b81a15c39a6c7104cb2f99503"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/c_AWPOLZVPHmGKC7CCrGXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1NA--/https://media.zenfs.com/en/globenewswire.com/8d20ac8b81a15c39a6c7104cb2f99503","width":300,"height":110}},"lazy":false},{"type":"text","content":"MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices, with two mega facilities based in Québec spanning over 1,600,000 sq. ft., today announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. (“Medican”), a wholly owned subsidiary of BZAM Ltd., for an aggregate purchase price of $2.8 million.","length":508,"tagName":"p"},{"type":"text","content":"This acquisition completes Cannara’s prior acquisition of its Valleyfield cultivation and manufacturing facility, purchased from Medican on June 8, 2021. The acquisition was completed following Medican’s exit from proceedings under the Companies’ Creditors Arrangement Act (“CCAA”) involving Medican’s parent company. Since the initial transaction in 2021, Medican has continued to refine its operating procedures, cultivation practices and post-harvest know-how, including unique extract manufacturing processes, providing Cannara with incremental operational expertise to support its continued growth.","length":603,"tagName":"p"},{"type":"text","content":"Leadership AppointmentCannara also announced today that Nicholas Sosiak has been appointed Chief Operating Officer, effective April 23, 2026. Mr. Sosiak, who has served as the Company's Chief Financial Officer since 2020, will transition fully into his new operational role while Cannara conducts a search for his successor as CFO.","length":337,"tagName":"p"},{"type":"text","content":""Nicholas has been an integral part of Cannara's growth and financial foundation. His deep understanding of cannabis, our products, and ultimately our business, combined with a proven track record of ...